MARKET

BGLC

BGLC

Bionexus Gene La
NASDAQ
4.330
-0.070
-1.59%
Closed 19:59 12/04 EST
OPEN
4.160
PREV CLOSE
4.400
HIGH
4.370
LOW
4.051
VOLUME
94.13K
TURNOVER
18.77K
52 WEEK HIGH
15.60
52 WEEK LOW
2.007
MARKET CAP
7.78M
P/E (TTM)
-3.3873
1D
5D
1M
3M
1Y
5Y
1D
12 Industrials Stocks Moving In Thursday's Pre-Market Session
Benzinga · 21h ago
12 Industrials Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
Bionexus Gene Lab completes investment in Fidelion Diagnostics
TipRanks · 1d ago
BioNexus Gene Lab Corp. Acquires 15% Stake in Fidelion Diagnostics
Reuters · 1d ago
BIONEXUS GENE LAB CORP. COMPLETES STRATEGIC INVESTMENT IN FIDELION DIAGNOSTICS; SECURES 15% EQUITY STAKE IN GLOBAL AI-ONCOLOGY PLATFORM AND EXCLUSIVE SOUTHEAST ASIAN RIGHTS FOR VITAGUARD™
Reuters · 1d ago
BIONEXUS GENE LAB CORP - BUYS 15% EQUITY STAKE IN FIDELION DIAGNOSTICS
Reuters · 1d ago
Bionexus Gene Lab secures $500M equity facility from ARC Group
TipRanks · 2d ago
BIONEXUS GENE LAB CORP - ENTERS $500 MLN EQUITY PURCHASE AGREEMENT
Reuters · 2d ago
More
About BGLC
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

Webull offers BioNexus Gene Lab Corp stock information, including NASDAQ: BGLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BGLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BGLC stock methods without spending real money on the virtual paper trading platform.